United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70010-186_4f19b9ad-53a9-da61-e063-6294a90afadf
- Product NDC
- 70010-186
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Granules Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230925
- Source listing expiry
- 20271231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-186-03) · 70010-186-03
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-186-05) · 70010-186-05
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-186-09) · 70010-186-09
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-186-10) · 70010-186-10
- 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-186-33) · 70010-186-33
- 8 BLISTER PACK in 1 CARTON (70010-186-63) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK · 70010-186-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →